
==== Front
Proc Natl Acad Sci U S A
Proc Natl Acad Sci U S A
PNAS
Proceedings of the National Academy of Sciences of the United States of America
0027-8424
1091-6490
National Academy of Sciences

202416854
10.1073/pnas.2416854121
si-correctSI CorrectionSI Correction
Correction to Supporting Information for Tili et al., MiR-155-targeted IcosL controls tumor rejection
9 9 2024
17 9 2024
9 9 2024
121 38 e24168541212024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).
==== Body
pmcMedical Sciences Correction to Supporting Information for “MiR-155-targeted IcosL controls tumor rejection,” by Esmerina Tili, Hajime Otsu, Teresa L. Commisso, Alexey Palamarchuk, Veronica Balatti, Jean-Jacques Michaille, Gerard James Nuovo, and Carlo M. Croce, which was published July 9, 2024; 10.1073/pnas.2408649121 (Proc. Natl. Acad. Sci. U.S.A. 121, e2408649121).

The authors note that SI Appendix, Fig. S4 appeared incorrectly. There was a typographical error in the legend of the first two top images, where Socs1 was labeled as red and CD20 as green. The correct labeling is that Socs1 is green and the CD20 is red.

The figure has been updated and the SI Appendix has been replaced.
